OPHLF (Ono Pharmaceutical Co) E10: $0.94 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OPHLF Ono Pharmaceutical Co Ltd OPHLF
85 GF Score
Price $15.86
GF Value $12.14
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ono Pharmaceutical Co E10?

Ono Pharmaceutical Co OPHLF 85 E10 is $0.94 as of Jun. 2026. GuruFocus rates OPHLF with a GF Score™ of 85/100 and a GF Value™ of $12.14 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ono Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2026 was $0.320. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.94 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Ono Pharmaceutical Co's average E10 Growth Rate was 8.20% per year. During the past 3 years, the average E10 Growth Rate was 15.00% per year. During the past 5 years, the average E10 Growth Rate was 18.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Ono Pharmaceutical Co was 22.90% per year. The lowest was 13.90% per year. And the median was 17.30% per year.

As of today (2026-08-28), Ono Pharmaceutical Co's current stock price is $15.86. Ono Pharmaceutical Co's E10 for the quarter that ended in Jun. 2026 was $0.94. Ono Pharmaceutical Co's Shiller PE Ratio of today is 16.87.

During the past 13 years, the highest Shiller PE Ratio of Ono Pharmaceutical Co was 67.10. The lowest was 9.95. And the median was 34.48.


Ono Pharmaceutical Co  (OTCPK:OPHLF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ono Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=15.86/0.94
=16.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Ono Pharmaceutical Co was 67.10. The lowest was 9.95. And the median was 34.48.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ono Pharmaceutical Co E10 Related Terms


Ono Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Ono Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co E10 Chart

Ono Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.81 0.92 1.05 0.94

Ono Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 0.96 0.97 0.94 0.94

OPHLF vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Shiller PE Ratio falls into.


OPHLF
85GF Score
Ono Pharmaceutical Co Ltd OPHLF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ono Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ono Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.32/113.6000*113.6000
=0.320

Current CPI (Jun. 2026) = 113.6000.

Ono Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201609 0.175 98.000 0.203
201612 0.315 98.400 0.364
201703 0.223 98.100 0.258
201706 0.201 98.500 0.232
201709 0.165 98.800 0.190
201712 0.348 99.400 0.398
201803 0.163 99.200 0.187
201806 0.269 99.200 0.308
201809 0.236 99.900 0.268
201812 0.248 99.700 0.283
201903 0.147 99.700 0.167
201906 0.295 99.800 0.336
201909 0.304 100.100 0.345
201912 0.349 100.500 0.394
202003 0.148 100.300 0.168
202006 0.400 99.900 0.455
202009 0.348 99.900 0.396
202012 0.514 99.300 0.588
202103 0.165 99.900 0.188
202106 0.438 99.500 0.500
202109 0.404 100.100 0.458
202112 0.323 100.100 0.367
202203 0.275 101.100 0.309
202206 0.451 101.800 0.503
202209 0.470 103.100 0.518
202212 0.506 104.100 0.552
202303 0.261 104.400 0.284
202306 0.461 105.200 0.498
202309 0.596 106.200 0.638
202312 0.526 106.800 0.559
202403 0.250 107.200 0.265
202406 0.334 108.200 0.351
202409 0.188 108.900 0.196
202412 0.265 110.700 0.272
202503 -0.094 111.100 -0.096
202506 0.260 111.700 0.264
202509 0.323 112.000 0.328
202512 0.394 113.000 0.396
202603 0.011 112.700 0.011
202606 0.320 113.600 0.320

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.94 mean?
Ono Pharmaceutical Co (OPHLF) has a E10 of $0.94 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ono Pharmaceutical Co and its competitors.
Is Ono Pharmaceutical Co's E10 too high?
Ono Pharmaceutical Co's current E10 is $0.94. Overall, Ono Pharmaceutical Co has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's E10 compare to LLY and JNJ?
Ono Pharmaceutical Co's E10 of $0.94 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ono Pharmaceutical Co and its competitors. Ono Pharmaceutical Co's current E10 is $0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ono Pharmaceutical Co (OPHLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $12.14, compared to a current price of $15.86 — trading 30.6% above its estimated fair value. The current E10 is $0.94. Ono Pharmaceutical Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Ono Pharmaceutical Co (OPHLF), the current E10 is $0.94 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ono Pharmaceutical Co (OPHLF) Overvalued in 2026?

Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued. The current stock price of $15.86 is trading 30.6% above its estimated GF Value™ of $12.14. GuruFocus considers Ono Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for OPHLF:

  • E10: $0.94
  • GF Value™: $12.14 vs. price of $15.86 (30.6% above fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the OPHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ono Pharmaceutical Co Business Description

Address 1-8-2 Kyutarocho, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
85GF Score

Get the complete analysis for OPHLF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.86
Price
$12.14
GF Value